Keyphrases
Older Adults
100%
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Hematopoietic Cell Transplant
100%
Peripheral Blood Stem Cell Graft
100%
Haploidentical
100%
Post-transplantation Cyclophosphamide (PTCy)
100%
Overall Survival
30%
Older Patients
23%
Risk Factors
15%
Disease Risk Prediction
15%
Unrelated Donor
15%
Donor Type
15%
Haploidentical Donor
15%
Treatment Options
7%
Hematological Malignancies
7%
Adult Patients
7%
Comorbidity
7%
Median Overall Survival
7%
Cox Proportional Hazards Model
7%
Anesthesia
7%
Poor Performance Status
7%
Disease Risk
7%
Age-related Illnesses
7%
Risk Analysis
7%
Transplant Patients
7%
Donor Pool
7%
Older Donors
7%
Risk Evaluation
7%
Relapse Risk
7%
HLA-matched Donor
7%
Peripheral Blood Stem Cells
7%
Non-relapse Mortality
7%
Comorbidity Index
7%
Clinical Deterioration
7%
Myeloablative Conditioning
7%
Age Impact
7%
Bone Marrow Graft
7%
Pre-transplant Evaluation
7%
Mobilized Peripheral Blood Stem Cells
7%
Medicine and Dentistry
Transplantation
100%
Myelodysplastic Syndrome
100%
Acute Myeloid Leukemia
100%
Cyclophosphamide
100%
Peripheral Blood Stem Cell
100%
Hematopoietic Cell
100%
Overall Survival
29%
Diseases
23%
Comorbidity
11%
Hematologic Malignancy
5%
Prospective Study
5%
Proportional Hazards Model
5%
Bone Marrow Transplantation
5%
Deterioration
5%
Age
5%
Patient History of Transplantation
5%
Myeloablative Conditioning
5%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Cyclophosphamide
100%
Diseases
80%
Comorbidity
40%
Hematologic Malignancy
20%
Prospective Study
20%
Deterioration
20%
Patient History of Transplantation
20%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Myeloid
100%
Cyclophosphamide
100%
Hematopoietic Cell
100%
Overall Survival
38%
Comorbidity
15%
Prospective Study
7%
Conditioning
7%
Age
7%
Immunology and Microbiology
Hematopoietic Cell
100%
Myeloid
100%
Peripheral Blood Stem Cell
100%
Cyclophosphamide
100%
Overall Survival
38%
Comorbidity
15%
Conditioning
7%
Age
7%
Neuroscience
Stem Cell
100%
Myeloid
100%
Cyclophosphamide
100%
Hematopoietic Cell
100%
Comorbidity
15%